An anti-inflammatory intravenous product may not benefit a patient whose principal limitation is chronic network plasticity, and a local trophic implant may not rescue acute mitochondrial failure
doi: 10.1210/er.2015-1104 33
However, this represents an off-label use without established protocols or evidence base
Ask any provider what the evidence looks like for your specific goal, whether the benefit is likely modest or meaningful, and how they will measure progress
It slows down the aging process, increases energy, reduces muscles and joint discomfort, improves mental focus, clarity and quality of sleep, reduces the effects of stress and improves athletic performance and recovery
In the literature, both peptides appear in the context of models involving soft tissues, endothelial function, actin organisation and cellular processes involved in repair and remodelling of biological structures